Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis.

Sugawara S, Yamada Y, Arai T, Okato A, Idichi T, Kato M, Koshizuka K, Ichikawa T, Seki N.

J Hum Genet. 2018 May;63(5):657-668. doi: 10.1038/s10038-018-0437-8. Epub 2018 Mar 14.

PMID:
29540855
2.

Inhibition of integrin β1-mediated oncogenic signalling by the antitumor microRNA-29 family in head and neck squamous cell carcinoma.

Koshizuka K, Kikkawa N, Hanazawa T, Yamada Y, Okato A, Arai T, Katada K, Okamoto Y, Seki N.

Oncotarget. 2017 Dec 11;9(3):3663-3676. doi: 10.18632/oncotarget.23194. eCollection 2018 Jan 9.

3.

Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells.

Suetsugu T, Koshizuka K, Seki N, Mizuno K, Okato A, Arai T, Misono S, Uchida A, Kumamoto T, Inoue H.

Int J Oncol. 2018 Mar;52(3):913-924. doi: 10.3892/ijo.2017.4232. Epub 2017 Dec 21.

PMID:
29286099
4.

Antitumor miR-150-5p and miR-150-3p inhibit cancer cell aggressiveness by targeting SPOCK1 in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Kikkawa N, Katada K, Okato A, Arai T, Idichi T, Osako Y, Okamoto Y, Seki N.

Auris Nasus Larynx. 2018 Aug;45(4):854-865. doi: 10.1016/j.anl.2017.11.019. Epub 2017 Dec 9.

PMID:
29233721
5.

Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.

Yamada Y, Koshizuka K, Hanazawa T, Kikkawa N, Okato A, Idichi T, Arai T, Sugawara S, Katada K, Okamoto Y, Seki N.

Int J Oncol. 2018 Jan;52(1):166-178. doi: 10.3892/ijo.2017.4190. Epub 2017 Nov 6.

6.

The microRNA expression signature of pancreatic ductal adenocarcinoma by RNA sequencing: anti-tumour functions of the microRNA-216 cluster.

Yonemori K, Seki N, Idichi T, Kurahara H, Osako Y, Koshizuka K, Arai T, Okato A, Kita Y, Arigami T, Mataki Y, Kijima Y, Maemura K, Natsugoe S.

Oncotarget. 2017 Jul 26;8(41):70097-70115. doi: 10.18632/oncotarget.19591. eCollection 2017 Sep 19.

7.

Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.

Okato A, Arai T, Yamada Y, Sugawara S, Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, Ichikawa T, Seki N.

Int J Mol Sci. 2017 Sep 13;18(9). pii: E1969. doi: 10.3390/ijms18091969.

8.

Involvement of aberrantly expressed microRNAs in the pathogenesis of head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Arai T, Okato A, Kikkawa N, Seki N.

Cancer Metastasis Rev. 2017 Sep;36(3):525-545. doi: 10.1007/s10555-017-9692-y. Review.

PMID:
28836104
9.

Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.

Arai T, Okato A, Kojima S, Idichi T, Koshizuka K, Kurozumi A, Kato M, Yamazaki K, Ishida Y, Naya Y, Ichikawa T, Seki N.

Cancer Sci. 2017 Oct;108(10):2088-2101. doi: 10.1111/cas.13331. Epub 2017 Aug 19.

10.

Regulation of SPOCK1 by dual strands of pre-miR-150 inhibit cancer cell migration and invasion in esophageal squamous cell carcinoma.

Osako Y, Seki N, Koshizuka K, Okato A, Idichi T, Arai T, Omoto I, Sasaki K, Uchikado Y, Kita Y, Kurahara H, Maemura K, Natsugoe S.

J Hum Genet. 2017 Nov;62(11):935-944. doi: 10.1038/jhg.2017.69. Epub 2017 Jun 29.

PMID:
28659612
11.

Regulation of ITGA3 by the anti-tumor miR-199 family inhibits cancer cell migration and invasion in head and neck cancer.

Koshizuka K, Hanazawa T, Kikkawa N, Arai T, Okato A, Kurozumi A, Kato M, Katada K, Okamoto Y, Seki N.

Cancer Sci. 2017 Aug;108(8):1681-1692. doi: 10.1111/cas.13298. Epub 2017 Jul 4.

12.

Dual strands of pre-miR‑150 (miR‑150‑5p and miR‑150‑3p) act as antitumor miRNAs targeting SPOCK1 in naïve and castration-resistant prostate cancer.

Okato A, Arai T, Kojima S, Koshizuka K, Osako Y, Idichi T, Kurozumi A, Goto Y, Kato M, Naya Y, Ichikawa T, Seki N.

Int J Oncol. 2017 Jul;51(1):245-256. doi: 10.3892/ijo.2017.4008. Epub 2017 May 17.

PMID:
28534948
13.

Deep sequencing-based microRNA expression signatures in head and neck squamous cell carcinoma: dual strands of pre-miR-150 as antitumor miRNAs.

Koshizuka K, Nohata N, Hanazawa T, Kikkawa N, Arai T, Okato A, Fukumoto I, Katada K, Okamoto Y, Seki N.

Oncotarget. 2017 May 2;8(18):30288-30304. doi: 10.18632/oncotarget.16327.

14.

ZFP36L2 promotes cancer cell aggressiveness and is regulated by antitumor microRNA-375 in pancreatic ductal adenocarcinoma.

Yonemori K, Seki N, Kurahara H, Osako Y, Idichi T, Arai T, Koshizuka K, Kita Y, Maemura K, Natsugoe S.

Cancer Sci. 2017 Jan;108(1):124-135. doi: 10.1111/cas.13119.

15.

Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.

Osako Y, Seki N, Kita Y, Yonemori K, Koshizuka K, Kurozumi A, Omoto I, Sasaki K, Uchikado Y, Kurahara H, Maemura K, Natsugoe S.

Int J Oncol. 2016 Dec;49(6):2255-2264. doi: 10.3892/ijo.2016.3745. Epub 2016 Oct 21.

16.

Regulation of TPD52 by antitumor microRNA-218 suppresses cancer cell migration and invasion in lung squamous cell carcinoma.

Kumamoto T, Seki N, Mataki H, Mizuno K, Kamikawaji K, Samukawa T, Koshizuka K, Goto Y, Inoue H.

Int J Oncol. 2016 Nov;49(5):1870-1880. doi: 10.3892/ijo.2016.3690. Epub 2016 Sep 13.

17.

Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.

Mataki H, Seki N, Mizuno K, Nohata N, Kamikawaji K, Kumamoto T, Koshizuka K, Goto Y, Inoue H.

Oncotarget. 2016 Nov 1;7(44):72084-72098. doi: 10.18632/oncotarget.12290.

18.

The tumor-suppressive microRNA-23b/27b cluster regulates the MET oncogene in oral squamous cell carcinoma.

Fukumoto I, Koshizuka K, Hanazawa T, Kikkawa N, Matsushita R, Kurozumi A, Kato M, Okato A, Okamoto Y, Seki N.

Int J Oncol. 2016 Sep;49(3):1119-29. doi: 10.3892/ijo.2016.3602. Epub 2016 Jul 4.

PMID:
27573718
19.

The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Okamoto Y, Seki N.

J Hum Genet. 2017 Jan;62(1):3-13. doi: 10.1038/jhg.2016.105. Epub 2016 Aug 25. Review.

PMID:
27557665
20.

Regulation of metastasis-promoting LOXL2 gene expression by antitumor microRNAs in prostate cancer.

Kato M, Kurozumi A, Goto Y, Matsushita R, Okato A, Nishikawa R, Fukumoto I, Koshizuka K, Ichikawa T, Seki N.

J Hum Genet. 2017 Jan;62(1):123-132. doi: 10.1038/jhg.2016.68. Epub 2016 Jun 9.

PMID:
27278788
21.

Dual-receptor (EGFR and c-MET) inhibition by tumor-suppressive miR-1 and miR-206 in head and neck squamous cell carcinoma.

Koshizuka K, Hanazawa T, Fukumoto I, Kikkawa N, Matsushita R, Mataki H, Mizuno K, Okamoto Y, Seki N.

J Hum Genet. 2017 Jan;62(1):113-121. doi: 10.1038/jhg.2016.47. Epub 2016 May 12.

PMID:
27169691
22.

Tumor-suppressive microRNAs (miR-26a/b, miR-29a/b/c and miR-218) concertedly suppressed metastasis-promoting LOXL2 in head and neck squamous cell carcinoma.

Fukumoto I, Kikkawa N, Matsushita R, Kato M, Kurozumi A, Nishikawa R, Goto Y, Koshizuka K, Hanazawa T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

J Hum Genet. 2016 Feb;61(2):109-18. doi: 10.1038/jhg.2015.120. Epub 2015 Oct 22.

PMID:
26490187
23.

[Aggravation after Diagnosis of Sudden Sensorineural Hearing Loss].

Fukumoto I, Nemoto T, Tsukuda T, Koshizuka K.

Nihon Jibiinkoka Gakkai Kaiho. 2015 Mar;118(3):201-5. Japanese.

PMID:
26349335
24.

MicroRNA expression signature of oral squamous cell carcinoma: functional role of microRNA-26a/b in the modulation of novel cancer pathways.

Fukumoto I, Hanazawa T, Kinoshita T, Kikkawa N, Koshizuka K, Goto Y, Nishikawa R, Chiyomaru T, Enokida H, Nakagawa M, Okamoto Y, Seki N.

Br J Cancer. 2015 Mar 3;112(5):891-900. doi: 10.1038/bjc.2015.19. Epub 2015 Feb 10.

25.

Successful tandem (autologous-cord blood) SCT in advanced neuroblastomas with highly amplified MYCN.

Goi K, Inukai T, Honna H, Akahane K, Hirose K, Kuroda I, Hasuda N, Koshizuka K, Takano K, Sugita K.

Bone Marrow Transplant. 2011 Jun;46(6):835-9. doi: 10.1038/bmt.2010.191. Epub 2010 Aug 9.

PMID:
20697365
26.

Effects of Rikkunshi-to on infantile hypertrophic pyloric stenosis, refractory to atropine.

Oyachi N, Takano K, Hasuda N, Arai H, Koshizuka K, Matsumoto M.

Pediatr Int. 2008 Aug;50(4):581-3. doi: 10.1111/j.1442-200X.2008.02682.x. No abstract available.

PMID:
18937758
27.

Perforation of Meckel's diverticulum manifesting as aseptic peritonitis in a neonate: report of a case.

Oyachi N, Takano K, Hasuda N, Arai H, Koshizuka K, Matsumoto M.

Surg Today. 2007;37(10):881-3. Epub 2007 Sep 26.

PMID:
17879039
28.

[Tamoxifen-induced severe hypertriglyceridemia--report of 3 cases].

Koshizuka K, Serizawa M, Hasuda N, Furuya K, Mouri N, Takano K, Matsumoto M.

Gan To Kagaku Ryoho. 2004 Jul;31(7):1109-12. Japanese.

PMID:
15272596
29.

[Delivery of twins after undergoing adjuvant LHRH analogue and CEF therapy].

Nakagomi H, Hada M, Koshizuka K, Muto S, Takano K.

Gan To Kagaku Ryoho. 2003 Apr;30(4):519-22. Japanese.

PMID:
12722685
30.

Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias.

Asou H, Koshizuka K, Kyo T, Takata N, Kamada N, Koeffier HP.

Int J Hematol. 2002 Jun;75(5):528-33.

PMID:
12095155
31.

[Effect of weekly docetaxel in patients with recurrent breast cancer].

Koshizuka K, Serizawa M, Mouri N, Muto S, Takano K, Tada Y, Nakagomi H, Hada M.

Gan To Kagaku Ryoho. 2001 Aug;28(8):1117-20. Japanese.

PMID:
11525028
32.

Prognostic and Therapeutic Implications of the MIB-1 Labeling Index in Breast Cancer.

Nakagomi H, Miyake T, Hada M, Hagiwara J, Furuya K, Muto S, Koshizuka K, Takano K, Kato R, Imamura K, Oyama T, Tada Y.

Breast Cancer. 1998 Jul 25;5(3):255-259.

PMID:
11091656
33.

Effects of long-term administration of vitamin D3 analogs to mice.

Smith EA, Frankenburg EP, Goldstein SA, Koshizuka K, Elstner E, Said J, Kubota T, Uskokovic M, Koeffler HP.

J Endocrinol. 2000 Apr;165(1):163-72.

PMID:
10750047
34.

[A case of recurrent breast cancer successfully treated with docetaxel].

Koshizuka K, Hada M, Muto S, Hagiwara J, Nakagomi H, Takano K, Kamiya K, Tada Y.

Gan To Kagaku Ryoho. 1999 Sep;26(10):1479-81. Japanese.

PMID:
10500538
35.

20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.

Koike M, Koshizuka K, Kawabata H, Yang R, Taub HE, Said J, Uskokovic M, Tsuruoka N, Koeffler HP.

Anticancer Res. 1999 May-Jun;19(3A):1689-97.

PMID:
10470102
36.

Combined effect of vitamin D3 analogs and paclitaxel on the growth of MCF-7 breast cancer cells in vivo.

Koshizuka K, Koike M, Asou H, Cho SK, Stephen T, Rude RK, Binderup L, Uskokovic M, Koeffler HP.

Breast Cancer Res Treat. 1999 Jan;53(2):113-20.

PMID:
10326788
37.

Combination therapy of a vitamin D3 analog and all-trans-retinoic acid: effect on human breast cancer in nude mice.

Koshizuka K, Kubota T, Said J, Koike M, Binderup L, Uskokovic M, Koeffler HP.

Anticancer Res. 1999 Jan-Feb;19(1A):519-24.

PMID:
10226591
38.

A comparison of prosthetic materials used to repair abdominal wall defects.

Mori N, Takano K, Miyake T, Nishio T, Muto S, Koshizuka K, Nakagomi H, Kubo M, Tada Y.

Pediatr Surg Int. 1998 Sep;13(7):487-90.

PMID:
9716675
39.

19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.

Kubota T, Koshizuka K, Koike M, Uskokovic M, Miyoshi I, Koeffler HP.

Cancer Res. 1998 Aug 1;58(15):3370-5.

40.

Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.

Kubota T, Koshizuka K, Williamson EA, Asou H, Said JW, Holden S, Miyoshi I, Koeffler HP.

Cancer Res. 1998 Aug 1;58(15):3344-52.

41.

Novel vitamin D3 analog (CB1093) when combined with paclitaxel and cisplatin inhibit growth of MCF-7 human breast cancer cells in vivo.

Koshizuka K, Koike M, Kubota T, Said J, Binderup L, Koeffler HP.

Int J Oncol. 1998 Sep;13(3):421-8.

PMID:
9683773
42.

Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice.

Elstner E, Müller C, Koshizuka K, Williamson EA, Park D, Asou H, Shintaku P, Said JW, Heber D, Koeffler HP.

Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8806-11.

43.

[Immunomodulatory effect of daily low-dose cisplatin treatment].

Nakagomi H, Hada M, Koshizuka K, Mutoh S, Watanabe K, Takano K, Horigome M, Yamadera Y, Iida B, Tada Y.

Gan To Kagaku Ryoho. 1997 Feb;24(3):323-7. Japanese.

PMID:
9051135
44.

Studies on the induction of prolonged immunotolerance by donor spleen transplantation.

Mouri N, Takano K, Muto S, Hada M, Nakagomi H, Koshizuka K, Tada Y.

Transplant Proc. 1994 Aug;26(4):1964-5. No abstract available.

PMID:
8066635
45.

Effect of growth hormone on wound healing in protein-malnourished rats treated with corticosteroids.

Takano K, Mouri N, Sakurai H, Muto S, Koshizuka K, Tada Y.

J Pediatr Surg. 1994 Jun;29(6):790-3.

PMID:
8078023

Supplemental Content

Loading ...
Support Center